Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.

Yoon J, Jeon JH, Lee YW, Cho CK, Kwon KR, Shin JE, Sagar S, Wong R, Yoo HS.

J Acupunct Meridian Stud. 2012 Aug;5(4):156-65. doi: 10.1016/j.jams.2012.05.003. Epub 2012 Jun 16.

2.

Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series.

Park JW, Jeon JH, Yoon J, Jung TY, Kwon KR, Cho CK, Lee YW, Sagar S, Wong R, Yoo HS.

Integr Cancer Ther. 2012 Jun;11(2):166-71. doi: 10.1177/1534735411413265. Epub 2011 Jun 28.

PMID:
21715371
3.

A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.

Kuroi K, Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Ohsumi S, Watanabe T, Bain S, Hausheer FH.

Jpn J Clin Oncol. 2008 Nov;38(11):748-54. doi: 10.1093/jjco/hyn100. Epub 2008 Oct 8.

PMID:
18845520
4.

Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography.

Schroeder S, Meyer-Hamme G, Epplée S.

Acupunct Med. 2012 Mar;30(1):4-7. doi: 10.1136/acupmed-2011-010034. Epub 2011 Dec 5.

PMID:
22146780
5.

A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).

Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L.

Support Care Cancer. 2017 Jan;25(1):195-204. Epub 2016 Sep 9.

PMID:
27612466
6.

A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.

Stubblefield MD, McNeely ML, Alfano CM, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463. Review.

7.

Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.

Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Katsumata N, Kuranami M, Suemasu K, Watanabe T, Hausheer FH.

Support Care Cancer. 2012 Dec;20(12):3355-64. doi: 10.1007/s00520-012-1492-x. Epub 2012 May 15.

PMID:
22584733
8.

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).

Kuroi K, Shimozuma K, Ohashi Y, Hisamatsu K, Masuda N, Takeuchi A, Aranishi T, Morita S, Ohsumi S, Hausheer FH.

Support Care Cancer. 2009 Aug;17(8):1071-80. doi: 10.1007/s00520-008-0550-x. Epub 2008 Dec 17.

PMID:
19089463
9.

Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, Cocito D, Padua L, Ghiglione E, Manicone M, Giussani G; Italian NETox Group.

J Peripher Nerv Syst. 2006 Jun;11(2):135-41.

PMID:
16787511
10.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.

Eur J Cancer. 2013 Sep;49(13):2910-8. doi: 10.1016/j.ejca.2013.04.004. Epub 2013 May 10.

PMID:
23668917
11.
12.

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Cavaletti G, Frigeni B, Lanzani F, Piatti M, Rota S, Briani C, Zara G, Plasmati R, Pastorelli F, Caraceni A, Pace A, Manicone M, Lissoni A, Colombo N, Bianchi G, Zanna C; Italian NETox Group.

J Peripher Nerv Syst. 2007 Sep;12(3):210-5.

PMID:
17868248
13.

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH.

Support Care Cancer. 2009 Dec;17(12):1483-91. doi: 10.1007/s00520-009-0613-7. Epub 2009 Mar 28.

PMID:
19330359
14.

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R; EORTC Quality of Life Group.

Eur J Cancer. 2005 May;41(8):1135-9. Epub 2005 Apr 14.

PMID:
15911236
15.

Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.

Beijers AJ, Vreugdenhil G, Oerlemans S, Eurelings M, Minnema MC, Eeltink CM, van de Poll-Franse LV, Mols F.

Support Care Cancer. 2016 Jun;24(6):2411-20. doi: 10.1007/s00520-015-3032-y. Epub 2015 Dec 3.

PMID:
26634561
16.

Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series.

Wong R, Sagar S.

Acupunct Med. 2006 Jun;24(2):87-91.

PMID:
16783284
17.

Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.

Hamza MA, White PF, Craig WF, Ghoname ES, Ahmed HE, Proctor TJ, Noe CE, Vakharia AS, Gajraj N.

Diabetes Care. 2000 Mar;23(3):365-70.

18.

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

Pachman DR, Barton DL, Watson JC, Loprinzi CL.

Clin Pharmacol Ther. 2011 Sep;90(3):377-87. doi: 10.1038/clpt.2011.115. Epub 2011 Aug 3. Review.

PMID:
21814197
19.

Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.

Al-Atiyyat N, Obaid A.

Int J Palliat Nurs. 2017 Jan 2;23(1):13-17. doi: 10.12968/ijpn.2017.23.1.13. Review.

PMID:
28132604
20.

Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study.

Sato J, Mori M, Nihei S, Takeuchi S, Kashiwaba M, Kudo K.

J Pharm Health Care Sci. 2017 Jul 25;3:21. doi: 10.1186/s40780-017-0089-4. eCollection 2017.

Supplemental Content

Support Center